img
img
images
Critical care

Albunorm

Albunorm 200 g/l solution for infusion, a bottle of 50 ml contains 10 g of human albumin

Human albumin

Albunorm 200 g/l solution for infusion, a bottle of 50 ml contains 10 g of human albumin.


Pharmaceutical form

Solution for infusion.


Therapeutic indications

Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate.


Method and duration of administration

Human albumin can be administered intravenously or can be diluted with isotonic solutions (e.g. 5% glucose or 0.9% sodium chloride).
Human albumin solutions must not be diluted with water for injections as this may cause haemolysis in recipients.


Contraindications

Hypersensitivity to albumin preparations or to any of the other excipients.


Special warnings and precautions for use

- Suspicion of allergic or anaphylactic type reactions.

- Albumin should be used with caution in conditions where hypervolaemia and its consequences or haemodilution could represent a special risk for the patient.

- Albunorm 20% 50 ml contains 7.2 –8 mmol sodium/bottle. This must be taken into consideration for patients on a controlled sodium diet.

- Albunorm 20% 50 ml contains a maximum of 0.5 mmol potassium/bottle. This must be taken into consideration for patients with reduced kidney function or patients on a controlled potassium diet.


Undesirable Effects

rarely Mild reactions such as flush, urticaria, fever, or nausea. These reactions normally disappear rapidly when the infusion rate is slowed down or the infusion is discontinued.

Very rarely, severe reactions such as shock may occur. In case of severe reactions, the infusion should be stopped immediately, and an appropriate treatment should be initiated.


Shelf life

3 years
After the vial has been opened, the content must be used immediately.


Special precautions for storage

Do not store above +25 °C.

Store in the outer carton in order to protect content from light.

Do not freeze.


Reference

Albunorm® - Summary of product characteristics.


Reporting of suspected adverse reactions

Reporting